• Login
    View Item 
    •   UMB Digital Archive
    • UMB Open Access Articles
    • UMB Open Access Articles
    • View Item
    •   UMB Digital Archive
    • UMB Open Access Articles
    • UMB Open Access Articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UMB Digital ArchiveCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Display statistics

    The economic burden of Parkinson disease among Medicare beneficiaries.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Author
    Albarmawi, Husam cc
    Zhou, Shujia
    Shulman, Lisa M
    Gandhi, Aakash Bipin
    Johnson, Abree
    Myers, Daniela E
    Gray, David
    Alvir, Jose
    Onukwugha, Eberechukwu
    Date
    2022-04-01
    Journal
    Journal of Managed Care & Specialty Pharmacy
    Publisher
    Academy of Managed Care Pharmacy (AMCP)
    Type
    Article
    
    Metadata
    Show full item record
    See at
    https://doi.org/10.18553/jmcp.2022.28.4.405
    Abstract
    BACKGROUND: The progressive nature of Parkinson disease (PD), together with a lack of curative treatments, contributes to its economic burden. OBJECTIVE: To estimate the longitudinal incremental costs attributable to PD among Medicare beneficiaries. METHODS: In this retrospective cohort study, we used data from the Chronic Conditions Data Warehouse to identify Medicare beneficiaries with and without PD-related claims identified from 2006 to 2014 with follow-up until 2015. We grouped PD cases and controls based on their survival profiles using a grouping algorithm that used the following baseline measures: age, race, sex, and comorbidity. We identified 3 survival groups and used them to stratify the descriptive annual cost estimates in the 9 years after the index date. We estimated the incremental 1-, 3-, and 5-year costs of PD using generalized linear models (GLM) that controlled for baseline factors. RESULTS: We identified 27,394 cases and controls who were grouped into 3 survival groups. The mean age of the full study sample was 73 years. No material differences were found in the incremental cost of PD across the survival groups. Based on the multivariable GLM, the 1-year incremental cost of PD was $9,625 (95% CI, $9,054-$10,197). The 3-year incremental cost of PD was $20,832 (95% CI, $19,390-$22,274). The 5-year incremental cost of PD was $27,466 (95% CI, 25,088-$29,844). CONCLUSIONS: Among Medicare beneficiaries, PD is associated with excess costs compared with controls. We did not identify substantial differences in the incremental cost of PD across the survival groups. DISCLOSURES:This study was funded by Pfizer Inc. The funding agreement did not impact the authors' independence in designing the study, collecting the data, interpreting the data, writing the manuscript, and submitting the manuscript for publication. Dr Onukwugha reports grants from Pfizer Inc for the conduct of this study and is an employee of University of Maryland, Baltimore, which received financial support from Pfizer Inc in connection with the development of this manuscript; Dr Shulman reports research funding from Pfizer Inc related to the current work, is an employee of University of Maryland, Baltimore, which received financial support from Pfizer Inc in connection with the development of this manuscript, and reports research funding from the NIH, The Rosalyn Newman Foundation, and the Eugenia and Michael Brin family unrelated to the current work and royalties from Oxford University Press and Johns Hopkins University Press; Ms Myers and Dr Alvir are employees and stockholders of Pfizer Inc; Dr Gray was an employee and stockholder of Pfizer Inc at the time of analysis.
    Identifier to cite or link to this item
    http://hdl.handle.net/10713/18537
    ae974a485f413a2113503eed53cd6c53
    10.18553/jmcp.2022.28.4.405
    Scopus Count
    Collections
    UMB Open Access Articles

    entitlement

    Related articles

    • The Prevalence and Cost of Medicare Beneficiaries Diagnosed and At Risk for Opioid Abuse, Dependence, and Poisoning.
    • Authors: Roland CL, Ye X, Stevens V, Oderda GM
    • Issue date: 2019 Jan
    • Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.
    • Authors: Pauly NJ, Talbert JC, Brown J
    • Issue date: 2016 Jun
    • The cost impact of disease progression to metastatic castration-sensitive prostate cancer.
    • Authors: Trinh QD, Chaves LP, Feng Q, Zhu J, Sandin R, Abbott T
    • Issue date: 2022 May
    • Comparative pharmacovigilance assessment of mortality with pimavanserin in Parkinson disease-related psychosis.
    • Authors: Brown JD, Cicali B, Henriksen C, Malaty I, Okun MS, Armstrong MJ
    • Issue date: 2021 Jun
    • Burden of Parkinson's Disease by Severity: Health Care Costs in the U.S. Medicare Population.
    • Authors: Dahodwala N, Li P, Jahnke J, Ladage VP, Pettit AR, Kandukuri PL, Bao Y, Zamudio J, Jalundhwala YJ, Doshi JA
    • Issue date: 2021 Jan
    DSpace software (copyright © 2002 - 2022)  DuraSpace
    Quick Guide | Policies | Contact Us | UMB Health Sciences & Human Services Library
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.